Medtronic (MDT $31.18) reported first quarter earnings of $0.79 per
share, excluding non-recurring items, in-line with the Capital IQ Consensus
Estimate consensus of $0.79.
Revenues rose 7.3% year/year to $4.05 billion versus the $3.98 billion
consensus.
The company reaffirmed its fiscal year 2012 earnings guidance of $3.43 to $3.50,
excluding non-recurring items, versus the $3.45 Capital IQ Consensus Estimate.
On the top line, the company is expecting to see revenue growth of +1% to +3%
year/year, which calculates to approx. $16.06 billion to $16.41 billion versus
the $16.55 billion Capital IQ Consensus Estimate.






